Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

DepoCyte is a slow-release formulation of cytarabine designed for intrathecal administration. The goal of this multi-centre cohort study was to determine the safety and efficacy of DepoCyte for the intrathecal treatment of neoplastic meningitis due to breast cancer. DepoCyte 50 mg was injected once...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaeckle, K A, Phuphanich, S, Bent, M J van den, Aiken, R, Batchelor, T, Campbell, T, Fulton, D, Gilbert, M, Heros, D, Rogers, L, O'Day, S J, Akerley, W, Allen, J, Baidas, S, Gertler, S Z, Greenberg, H S, LaFollette, S, Lesser, G, Mason, W, Recht, L, Wong, E, Chamberlain, M C, Cohn, A, Glantz, M J, Gutheil, J C, Maria, B, Moots, P, New, P, Russell, C, Shapiro, W, Swinnen, L, Howell, S B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363714/
https://www.ncbi.nlm.nih.gov/pubmed/11161370
http://dx.doi.org/10.1054/bjoc.2000.1574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363714/
https://www.ncbi.nlm.nih.gov/pubmed/11161370
http://dx.doi.org/10.1054/bjoc.2000.1574

Ejemplares similares